Cargando…

Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells

Tyrosine kinase inhibitors (TKIs) are currently the first-line treatment for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. These patients receive platinum-based chemotherapy as the second-line treatment after they develop resistance to TKIs. Many...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, An-Fu, Chen, Man-Chin, Chen, Chao-Ju, Yang, Chih-Jen, Huang, Ming-Shyang, Liu, Yu-Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500319/ https://www.ncbi.nlm.nih.gov/pubmed/28683123 http://dx.doi.org/10.1371/journal.pone.0180383

Ejemplares similares

Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade
por: Luttman, Jillian Hattaway, et al.
Publicado: (2021)

Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition
por: Sun, Chris K., et al.
Publicado: (2011)

SAT-335 Resistin Induces Epithelial to Mesenchymal Transition (EMT) in Breast Cancer Cells through Activation of AXL Tyrosine Kinase Receptor
por: Weber, Daniel, et al.
Publicado: (2019)

Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinase
por: Zhang, Nan-nan, et al.
Publicado: (2020)

Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
por: Chengye, Wang, et al.
Publicado: (2017)

Triptolide reverses epithelial-mesenchymal transition in glioma cells via inducing autophagy
por: Lai, Minfang, et al.
Publicado: (2021)

Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
por: Qin, Yuan, et al.
Publicado: (2015)

Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells
por: Hänze, Jörg, et al.
Publicado: (2013)

Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Blocks and Reverses Epithelial to Mesenchymal Transition of Mesothelial Cells
por: Strippoli, Raffaele, et al.
Publicado: (2012)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: Makena, Monish Ram, et al.
Publicado: (2021)

Targeting Mitochondrial ROS Production to Reverse the Epithelial-Mesenchymal Transition in Breast Cancer Cells
por: Monti, Elena, et al.
Publicado: (2022)

A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells
por: LI, JIANPING, et al.
Publicado: (2014)

Influence of Bruton’s Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Leichtle, Franziska, et al.
Publicado: (2023)

RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis
por: Wang, Qinglian, et al.
Publicado: (2018)

Boolean modeling of mechanosensitive epithelial to mesenchymal transition and its reversal
por: Sullivan, Emmalee, et al.
Publicado: (2023)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells
por: Matoba, Ryo, et al.
Publicado: (2017)

Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
por: Krantz, Seth B., et al.
Publicado: (2010)

SET contributes to the epithelial-mesenchymal transition of pancreatic cancer
por: Mody, Hardik R., et al.
Publicado: (2017)

Contribution of epithelial-mesenchymal transitions to organogenesis and cancer metastasis
por: Campbell, Kyra
Publicado: (2018)

Ectopic pregnancy and epithelial to mesenchymal transition: is there a link?
por: Flanagan, Heather, et al.
Publicado: (2020)

Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells
por: Llorián-Salvador, María, et al.
Publicado: (2022)

14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
por: Liu, Tzu-An, et al.
Publicado: (2013)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis
por: Wu, Jingni, et al.
Publicado: (2020)

Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
por: Ho, Nguyen-Tuong, et al.
Publicado: (2022)

Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway
por: Zheng, Qiaomei, et al.
Publicado: (2020)

Optogenetic control of epithelial-mesenchymal transition in cancer cells
por: Zhou, Xiaoxu, et al.
Publicado: (2018)

A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition
por: Miyoshi, Seigo, et al.
Publicado: (2015)

Human dermal fibroblast subpopulations and epithelial mesenchymal transition signals in hidradenitis suppurativa tunnels are normalized by spleen tyrosine kinase antagonism in vivo
por: Flora, Akshay, et al.
Publicado: (2023)

Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
por: Yu, Dinglai, et al.
Publicado: (2017)

Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition
por: Seol, Min A., et al.
Publicado: (2019)

Nrf2 Downregulation Contributes to Epithelial-to-Mesenchymal Transition in Helicobacter pylori-Infected Cells
por: Bacon, Sarah, et al.
Publicado: (2022)

NKX3.1 Expression Contributes to Epithelial–Mesenchymal Transition of Prostate Cancer Cells
por: Saydullaeva, Iroda, et al.
Publicado: (2023)

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition
por: ANTOON, JAMES W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_urj29cuhhf0ab39osjoi3ltv8t